Analystreport

NeuBase Therapeutics (NASDAQ: NBSE) was downgraded by analysts at ValuEngine from a "hold" rating to a "sell" rating.

NeuBase Therapeutics, Inc.  (NBSE) 
Last neubase therapeutics, inc. earnings: 3/26 04:05 pm Check Earnings Report